Thomas Taapken

Executive Chairman

Thomas Taapken is an independent adviser with over 20 years of experience in the life sciences sector at senior management and board levels. Prior to joining Imcyse, he held executive management positions at several private and publicly listed companies, including Medigene AG, Epigenomics AG and Biotie Therapies. He also served on the board of private and listed companies such as Scibase AB, Immunic AG and others. He successfully completed public and private financings, business and M&A transactions and worked in venture capital in both Germany and the US. Taapken holds a Ph.D. in organic chemistry from the Technical University of Berlin and has also studied economics and physics at the University of Göttingen. 

Marcelle Van Mechelen

PhD, Senior Scientific Advisor

Jean Smal

PhD, Senior Advisor, Development and Manufacturing

Vincent Carlier

PhD, R&D Director, Immunology

Marie Gérard

Corporate Governance, HR & Finance Director

Geoffrey Gloire

PhD, IP Director

Luc Vander Elst

R&D Director, In Vivo and Imotope Development

Jean Van Rampelbergh

PhD, Clinical Director